These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23845470)

  • 1. Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.
    Salajegheh A; Pakneshan S; Rahman A; Dolan-Evans E; Zhang S; Kwong E; Gopalan V; Lo CY; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2204-12. PubMed ID: 23845470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma.
    Salajegheh A; Vosgha H; Rahman MA; Amin M; Smith RA; Lam AK
    Hum Pathol; 2016 May; 51():75-85. PubMed ID: 27067785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas.
    Fellmer PT; Sato K; Tanaka R; Okamoto T; Kato Y; Kobayashi M; Shibuya M; Obara T
    Surgery; 1999 Dec; 126(6):1056-61; discussion 1061-2. PubMed ID: 10598188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression.
    Salajegheh A; Dolan-Evans E; Sullivan E; Irani S; Rahman MA; Vosgha H; Gopalan V; Smith RA; Lam AK
    Exp Mol Pathol; 2014 Apr; 96(2):212-8. PubMed ID: 24530443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers.
    Maroof H; Irani S; Arianna A; Vider J; Gopalan V; Lam AK
    Curr Cancer Drug Targets; 2019; 19(7):561-570. PubMed ID: 29956628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
    Wang T; Jiang CX; Li Y; Liu X
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma.
    Selemetjev S; Savin S; Paunovic I; Tatic S; Cvejic D
    J Cancer Res Ther; 2018; 14(Supplement):S114-S119. PubMed ID: 29578160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
    Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma].
    Jiang HG; Gao M; Tang WP; Li FH; Cai QZ
    Ai Zheng; 2005 Sep; 24(9):1136-9. PubMed ID: 16159441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer.
    Salajegheh A; Vosgha H; Md Rahman A; Amin M; Smith RA; Lam AK
    J Mol Endocrinol; 2015 Dec; 55(3):183-96. PubMed ID: 26342107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
    Meng XY; Zhang Q; Li Q; Lin S; Li J
    J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors.
    Hung CJ; Ginzinger DG; Zarnegar R; Kanauchi H; Wong MG; Kebebew E; Clark OH; Duh QY
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3694-9. PubMed ID: 12915657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma.
    Yasuoka H; Nakamura Y; Zuo H; Tang W; Takamura Y; Miyauchi A; Nakamura M; Mori I; Kakudo K
    Mod Pathol; 2005 Aug; 18(8):1127-33. PubMed ID: 15803188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of nuclear protein kinase CK2α as a poor prognosis indicator in lymph node cancerous metastases of human thyroid cancers.
    Guo M; Liu C; Qi FJ; Zhang XM; Ren LL; Liu YM; Meng ZC; Zhu ZT; Xiao JY
    Asian Pac J Cancer Prev; 2014; 15(17):7425-32. PubMed ID: 25227853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
    Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma.
    Šelemetjev S; Ðoric I; Paunovic I; Tatic S; Cvejic D
    Am J Clin Pathol; 2016 Nov; 146(5):594-602. PubMed ID: 27806941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
    J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
    Tuttle RM; Fleisher M; Francis GL; Robbins RJ
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
    Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.